Genomic organization and chromosomal location of the mouse vasoactive intestinal polypeptide 1 (VPAC1) receptor

Genomics

Volumn 58, Issue 1, 1999, Pages 90-93

  Hashimoto, Hitoshi ^a   Nishino, Akiko ^a   Shintani, Norihito ^a   Hagihara, Nami ^a   Copeland, Neal G ^b   Jenkins, Nancy A ^b   Yamamoto, Kyohei ^a   Matsuda, Toshio ^a   Ishihara, Takeshi ^c   Nagata, Shigekazu ^d   Baba, Akemichi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF GENETICS   (Japan)

^d OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING SITE; CHROMOSOMAL LOCALIZATION; DNA FLANKING REGION; GENE MAPPING; GENETIC ANALYSIS; GENETIC CODE; GENETIC ORGANIZATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR AFFINITY; RECEPTOR GENE; TATA BOX;

ANIMALIA; RODENTIA;

EID: 0033563230     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1999.5805     Document Type: Article

References (23)

1. Aino H., Hashimoto H., Ogawa N., Nishino A., Yamamoto K., Nogi H., Nagata S., Baba A. Structure of the gene encoding the mouse pituitary adenylate cyclase-activating polypeptide receptor. Gene. 164:1995;301-304.
2. Arimura A. Pituitary adenylate cyclase activating polypeptide (PACAP): Discovery and current status of research. Regul. Pept. 37:1992;287-303.
3. Breathnach R., Chambon P. Organization and expression of eucaryotic split genes coding for proteins. Annu. Rev. Biochem. 50:1981;349-383.
4. Copeland N. G., Jenkins N. A. Development and applications of a molecular genetic linkage map of the mouse genome. Trends Genet. 7:1991;113-118.
5. Gozes I., Brenneman D. E. VIP: Molecular biology and neurobiological function. Mol. Neurobiol. 3:1989;201-236.
6. Hardiman G., Jenkins N. A., Copeland N. G., Gilbert D. J., Garcia D. K., Naylor S. L., Kastelein R. A., Bazan J. F. Genetic structure and chromosomal mapping of MyD88. Genomics. 45:1997;332-339.
7. Harmar A. J., Arimura A., Gozes I., Journot L., Laburthe M., Pisegna J. R., Rawlings S. R., Robberecht P., Said S. I., Sreedharan S. P., Wank S. A., Waschek J. A. International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol. Rev. 50:1998;265-270.
8. Harmar T., Lutz E. Multiple receptors for PACAP and VIP. Trends Pharmacol. Sci. 15:1994;97-99.
9. Hashimoto H., Ishihara T., Shigemoto R., Mori K., Nagata S. Molecular cloning and tissue distribution of a receptor for pituitary adenylate cyclase-activating polypeptide. Neuron. 11:1993;333-342.
10. Hosoya M., Kimura C., Ogi K., Ohkubo S., Miyamoto Y., Kugoh H., Shimizu M., Onda H., Oshimura M., Arimura A., Fujino M. Structure of the human pituitary adenylate cyclase activating polypeptide (PACAP) gene. Biochim. Biophys. Acta. 1129:1992;199-206.
11. Imagawa M., Chiu R., Karin M. Transcription factor AP-2 mediates induction by two different signal-transduction pathways: Protein kinase C and cAMP. Cell. 51:1987;251-260.
12. Ishihara T., Shigemoto R., Mori K., Takahashi K., Nagata S. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron. 8:1992;811-819.
13. Jenkins N. A., Copeland N. G., Taylor B. A., Lee B. K. Organization, distribution, and stability of endogenous ecotropic murine leukemia virus DNA sequences in chromosomes ofMus musculus. J. Virol. 43:1982;26-36.
14. Johnson M. C., McCormack R. J., Delgado M., Martinez C., Ganea D. Murine T-lymphocytes express vasoactive intestinal peptide receptor 1 (VIP-R1) mRNA. J. Neuroimmunol. 68:1996;109-119.
15. Kadonaga J. T., Carner K. R., Masiarz F. R., Tjian R. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell. 51:1987;1079-1090.
16. Lock L. F., Wickramasinghe D., Ernst M. K., Gilbert D. J., Copeland N. G., Jenkins N. A., Donovan P. J. The Cdc25 genes map to mouse chromosomes 2, 9, and 18. Mamm. Genome. 7:1996;771-772.
17. Mackay M., Fantes J., Scherer S., Boyle S., West K., Tsui L. C., Belloni E., Lutz E., Van Heyningen V., Harmar A. J. Chromosomal localization in mouse and human of the vasoactive intestinal peptide receptor type 2 gene: A possible contributor to the holoprosencephaly 3 phenotype. Genomics. 37:1996;345-353.
18. Metwali A., Elliott D., Blum A. M., Li J., Sandor M., Weinstock J. V. T cell vasoactive intestinal peptide receptor subtype expression differs between granulomas and spleen of schistosome-infected mice. J. Immunol. 157:1996;265-270.
19. Pei L. Identification of a negative glucocorticoid response element in the rat type 1 vasoactive intestinal polypeptide receptor gene. J. Biol. Chem. 271:1996;20879-20884.
20. Pei L., Melmed S. Characterization of the rat vasoactive intestinal polypeptide receptor gene 5′ region. Biochem. J. 308:1995;719-723.
21. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
22. Sreedharan S. P., Huang J. X., Cheung M. C., Goetzl E. J. Structure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene. Proc. Natl.Acad. Sci. USA. 92:1995;2939-2943.
23. Yamamoto K., Hashimoto H., Hagihara N., Nishino A., Fujita T., Matsuda T., Baba A. Cloning and characterization of the mouse pituitary adenylatecyclase-activating polypeptide (PACAP) gene. Gene. 211:1998;63-69.